LYCA logo

Lycia Therapeutics Inc.

LYCA
Healthcare|Biotechnology|US
$30.50
+1.70 (+5.90%)
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Oct 23, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (1)

Apr 2028
Est. completion
P1Atopic Disease
Single Ascending and Multiple Ascending Dose Study of LCA-0061
NCT07701954n=72

Recent Press Releases

Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Oct 26, 2026 · GlobeNewsWire
Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering
Oct 22, 2026 · GlobeNewsWire

SEC Filings (13)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 26, 20268-KMaterial eventDocumentIndex
Oct 23, 2026S-8Employee stock planDocumentIndex
Oct 23, 2026424B4Offering prospectusDocumentIndex
Oct 22, 2026EFFECTDocumentIndex
Oct 22, 2026S-1MEFIPO / offering registrationDocumentIndex
Oct 22, 2026CERTDocumentIndex
Oct 20, 20268-A12BDocumentIndex
Oct 20, 2026S-1/AIPO / offering registrationDocumentIndex
Oct 5, 2026S-1IPO / offering registrationDocumentIndex
Aug 27, 2026DRS/ADocumentIndex
Jul 2, 2026DRSDocumentIndex
Jun 25, 2026DDocumentIndex